Coffee review

The study says drinking two cups of coffee a day can reduce the risk of liver cancer by 43%.

Published: 2024-11-05 Author: World Gafei
Last Updated: 2024/11/05, According to Singapore's Lianhe Zaobao, Lasson of the Karolinska College of Medicine in Sweden and Dr. Volcker jointly published a report in the American Journal of Gastroenterology. The medical community has accumulated a lot of research data on the potential benefits of coffee on liver function and liver disease in the past 20 years. Several studies have found that drinking coffee is inversely proportional to liver enzyme levels, while liver enzyme levels are associated with the disease.

According to Singapore's Lianhe Zaobao, Lasson of Karolinska College of Medicine in Sweden and Dr. Volcker jointly published a report in the American Journal of Gastroenterology. The medical community has accumulated a lot of research data on the potential benefits of coffee on liver function and liver disease in the past 20 years. Several studies have found that coffee drinking is inversely proportional to liver enzyme levels, and liver enzyme levels are associated with chronic liver disease and cirrhosis.

The researchers then conducted a large-scale review of published epidemiological studies to find out the relationship between coffee drinking and the risk of liver cancer. They conducted a consolidated analysis of the results of 11 studies involving 2260 patients with liver cancer and 230000 9146 healthy people who were used for comparative studies.

The researchers found that all studies showed that coffee drinking was inversely proportional to the risk of liver cancer, and the relationship was particularly pronounced in six of the studies.

Lasson and Volcker point out that coffee contains large amounts of antioxidants such as chlorogenic acid (chlorogenic acid), which can fight oxidative stress (oxidative stress) and prevent the formation of carcinogens. In addition, experiments in animals have clearly shown that coffee and chlorogenic acid have an inhibitory effect on liver cancer.

0